NCT01825603 2023-12-28
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
University of Nebraska
Phase 1 Completed
Clinical Trials
4 trialsNCT00265057 2010-12-28
Study of ADH-1 Given Intravenously to Patients With Solid Tumors
Adherex Technologies, Inc.
Phase 1/2 Completed
NCT00225550 2007-08-06
A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors
Adherex Technologies, Inc.
Phase 1/2 Terminated
NCT00264433 2007-08-06
A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent
Adherex Technologies, Inc.
Phase 2 Completed